Genetically engineered mouse models are critical for the research programs of Koch Institute Members. They are used to probe the role of cancer genes in cell and developmental biology, investigate the mechanisms of tumor development, progression and metastasis, evaluate drug response and resistance, and test novel strategies and devices for tumor detection and drug delivery. The ES Cell & Transgenics Core is an Institutional Shared Resource that provides Koch Institute investigators with consultative advice, technical support and/or training in the production of engineered cells and mouse models. In the current period, the capabilities of this Core have been further expanded and enhanced. This includes moving into a larger, custom-designed space in the new Koch Institute building, the addition of new services and a reorganization of the staff to support novice users and provide project-customized services. Notably, in the same period, usage of the ES Cell & Transgenics Core by Center Members increased from 29% to 51%, including investigators from all four programs. Thus, this Shared Resource is essential to the success of the Koch Institute mission. In the upcoming period, the ES Cell & Transgenics Core will continue to offer a wide range of state-of-the-art services to support the research programs of Center Members. In spite of the significant expansion of services and usage, the requested CCSG budget for Year 44 is 13% lower than the requested and recommended budget in Year 39.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014051-48
Application #
9693621
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-05-01
Budget End
2020-04-30
Support Year
48
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Massachusetts Institute of Technology
Department
Type
DUNS #
001425594
City
Cambridge
State
MA
Country
United States
Zip Code
02142
Wong, Madeline Y; Doan, Ngoc Duc; DiChiara, Andrew S et al. (2018) A High-Throughput Assay for Collagen Secretion Suggests an Unanticipated Role for Hsp90 in Collagen Production. Biochemistry 57:2814-2827
Danai, Laura V; Babic, Ana; Rosenthal, Michael H et al. (2018) Altered exocrine function can drive adipose wasting in early pancreatic cancer. Nature 558:600-604
Dubbury, Sara J; Boutz, Paul L; Sharp, Phillip A (2018) CDK12 regulates DNA repair genes by suppressing intronic polyadenylation. Nature 564:141-145
Tokatlian, Talar; Kulp, Daniel W; Mutafyan, Andrew A et al. (2018) Enhancing Humoral Responses Against HIV Envelope Trimers via Nanoparticle Delivery with Stabilized Synthetic Liposomes. Sci Rep 8:16527
Crowell, Laura E; Lu, Amos E; Love, Kerry R et al. (2018) On-demand manufacturing of clinical-quality biopharmaceuticals. Nat Biotechnol :
Lo, Justin H; Hao, Liangliang; Muzumdar, Mandar D et al. (2018) iRGD-guided Tumor-penetrating Nanocomplexes for Therapeutic siRNA Delivery to Pancreatic Cancer. Mol Cancer Ther 17:2377-2388
Berger, Gilles; Grauwet, Korneel; Zhang, Hong et al. (2018) Anticancer activity of osmium(VI) nitrido complexes in patient-derived glioblastoma initiating cells and in vivo mouse models. Cancer Lett 416:138-148
Johnson, Hannah; White, Forest M (2018) Quantitative Analysis of Tyrosine Kinase Signaling Across Differentially Embedded Human Glioblastoma Tumors. Methods Mol Biol 1711:149-164
Phillips, Angela M; Doud, Michael B; Gonzalez, Luna O et al. (2018) Enhanced ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin. Elife 7:
Parisi, Tiziana; Balsamo, Michele; Gertler, Frank et al. (2018) The Rb tumor suppressor regulates epithelial cell migration and polarity. Mol Carcinog 57:1640-1650

Showing the most recent 10 out of 904 publications